The Singapore approach to human stem cell research, therapeutic and reproductive cloning.
With the controversial ethical issues on the creation of human embryos through cloning for therapeutic research, which holds more promise of medical breakthroughs that the world could ever imagine and the acknowledgement by many scientists that this technology may not lead in the near future to therapies; this country report discusses the approach Singapore takes on human stem cell research, interjected with the authors' own arguments and suggestions especially on research compensation injuries, an often neglected important issue. International comparative viewpoints taken by the major countries in the world are also included in the appendix.
Kian
Catherine Tay Swee
CT
32 Sunset View, Singapore, 59714. biztayc@nus.edu.sg
Leng
Tien Sim
TS
D037881:Aborted Fetus / Q000166:cytology; D000328:Adult; D026683:Advisory Committees; D019976:Cloning, Organism / Q000941:ethics / Q000331:legislation & jurisprudence; D019924:Embryo Disposition / Q000941:ethics; D033041:Embryo Research / Q000941:ethics / Q000331:legislation & jurisprudence; D004622:Embryo, Mammalian / Q000166:cytology; D005307:Fertilization in Vitro; D033161:Government Regulation; D017408:Guidelines as Topic; D006801:Humans; D007258:Informed Consent; D038622:Internationality; D007878:Legislation as Topic; D011640:Public Policy; D012846:Singapore; D012926:Social Control, Formal; D013234:Stem Cells; D014019:Tissue Donors